Scarica l'app Stockscreener
19.13
4.11%
-0.82
Dopo l'orario di chiusura:
19.13
Uniqure Nv Borsa (QURE) Ultime notizie
Update: UniQure Shares Rise After Firm Plans to Submit UK Marketing Application for Huntington's Disease Treatment - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
MSN Money - MSN
uniQure (QURE) Shares Surge 22% on Positive Regulatory News for AMT-130 - GuruFocus
uniQure stock rises after regulatory updates (QURE:NASDAQ) - Seeking Alpha
uniQure (NASDAQ:QURE) Shares Gap UpHere's Why - MarketBeat
UniQure Plans to Submit UK Marketing Authorization Application for Huntington's Disease Treatment - marketscreener.com
uniQure plans UK filing for Huntington’s gene therapy AMT-130 By Investing.com - Investing.com India
uniQure meets with UK MHRA on AMT-130 for Huntington’s disease - The Pharma Letter
Aberdeen Group (QURE) reports 5.31M shares, 8.49% stake | Schedule 13G/A - Stock Titan
uniQure advances AMT-130 toward UK marketing approval - TipRanks
uniQure plans UK filing for Huntington’s gene therapy AMT-130 - Investing.com
AMT-130 Huntington’s gene therapy nears UK filing for uniQure (NASDAQ: QURE) - Stock Titan
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease - GlobeNewswire
Earnings Preview: UniQure NV to Report Financial Results Pre-market on May 05 - 富途牛牛
QURE stock crashes 32% in a week: Here's what you should know - MSN
QURE Stock Just Shot Up 8%uniQure’s Much-Talked-About Huntington’s Disease Therapy Gets A UK Boost - Stocktwits
uniQure N.V. (NASDAQ:QURE) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
UniQure used 'distorted comparison' in Huntington's asset trial: FDA official - MSN
UniQure surges following departure of key FDA official - MSN
Before the bell, uniQure posts Q1 numbers and takes questions May 5 - Stock Titan
uniQure to Announce First Quarter 2026 Financial Results - Sahm
uniQure NV (MEX:QUREN) Stock Earnings Transcripts - GuruFocus
uniQure (NASDAQ: QURE) outlines 2026 proxy agenda, equity and charter changes - Stock Titan
[ARS] uniQure N.V. SEC Filing - Stock Titan
(QURE) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
uniQure announces $200 million proposed public offering - MSN
QURE Forecast, Price Target & Analyst Ratings | UNIQURE NV (NASDAQ:QURE) - ChartMill
QURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data (PR Newswire) - Aktiellt
uniQure N.V. (QURE) Stock Outlook | Q4 2025: Profit Exceeds ViewsROCE - Xã Châu Thành
uniQure N.V. (QURE) Stock Posts 30% Growth from Last Year - Insider Monkey
QURE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
uniQure NV (MEX:QUREN) Short-term investments - GuruFocus
Barclays reaffirms equal weight rating for uniQure (QURE) - MSN
uniQure Shares Collapse 75% After FDA Reverses Position on Huntington’s Therapy - MSN
QURE Maintained by Goldman Sachs -- Price Target Raised to $10.0 - GuruFocus
uniQure N.V. (QURE) Stock: Fair Value Assessment (Extends Gains) 2026-04-20Trade Ideas - Cổng thông tin điện tử tỉnh Tây Ninh
uniQure N.V. (QURE) Stock Virtual Order (+4.58%) 2026-04-18Community Volume Signals - Cổng thông tin điện tử Tỉnh Sơn La
uniQure NV Stock Operating Data - GuruFocus
uniQure NV (MEX:QUREN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
uniQure NV (MEX:QUREN) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Q4 2025 Uniqure NV Earnings Call Transcript - GuruFocus
uniQure NV (MEX:QUREN) Stock Price & 30 Year Financial Data - GuruFocus
Uniqure NV at TD Cowen Healthcare Conference Transcript - GuruFocus
Total debt per share of uniQure N.V. – SWB:UQ1 - TradingView
uniQure N.V. (NASDAQ:QURE) Sees Significant Decrease in Short Interest - MarketBeat
UniQure NV (NASDAQ:QURE) Q4 2025 earnings call transcript - MSN
uniQure N.V. (QURE) Stock Analysis: Navigating a 129.74% Potential Upside in Biotechnology - DirectorsTalk Interviews
uniQure (Nasdaq: QURE) requests 12.4M-share delegation, 10% buyback - Stock Titan
(QURE) Risk Channels and Responsive Allocation - Stock Traders Daily
UniQure shares surge 26% on US FDA shakeup even as momentum tumbles: Will new leadership greenlight Huntington's therapy? - MSN
2.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):